BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.

BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that …

Mar 10, 2026 · BioNTech co-founders and mRNA technology pioneers Prof. Ugur Sahin, M.D., and Prof. Özlem Türeci, M.D., will establish their third biotechnology company following the foundation of …

Mar 10, 2026 · BioNTech, which developed and sold the COVID-19 shot with Pfizer (PFE.N), said it plans to contribute certain rights and mRNA technologies to the new company on an arm's-length …

Apr 3, 2026 · Products Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.

Mar 10, 2026 · With sales of Covid-19 shots dwindling, the biotech company is looking to accelerate efforts to develop new products.

Mar 10, 2026 · The husband-and-wife founders of German vaccine company BioNTech announced on Tuesday they would step down to pursue new innovations at a brand new firm.

4 days ago · An experimental, individualized therapeutic cancer vaccine that uses messenger RNA (mRNA) to treat pancreatic cancer continues to show potential in a small patient group. Follow-up …

Mar 10, 2026 · BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine, dashing investors’ …

Mar 10, 2026 · Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and …